Effective wound management and infection prevention require more than a conventional antimicrobial approach. Biofilm has emerged as one of the most significant factors associated with persistent microbial contamination, delayed healing, and clinical complications.
MedicalPath focuses on advanced technologies with documented antimicrobial and anti-biofilm activity, supporting the clinical management of both acute and chronic wounds, including pressure ulcers, diabetic foot ulcers, surgical wounds, and other high-risk conditions.
Supported by published scientific evidence, these solutions contribute to the reduction of microbial burden, the control of biofilm, and the creation of an optimal environment for tissue healing.